Chronic obstructive pulmonary disease * 12: New treatments for COPD.
作者信息
Barnes P J
机构信息
National Heart and Lung Institute, Imperial College School of Medicine, London SW3 6LY, UK.
出版信息
Thorax. 2003 Sep;58(9):803-8. doi: 10.1136/thorax.58.9.803.
Abstract
摘要
相似文献
1
Chronic obstructive pulmonary disease * 12: New treatments for COPD.慢性阻塞性肺疾病*12：慢性阻塞性肺疾病的新疗法
Thorax. 2003 Sep;58(9):803-8. doi: 10.1136/thorax.58.9.803.
2
New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.慢性阻塞性肺疾病的新疗法及吸入疗法的可行制剂/装置选择。
Expert Opin Drug Deliv. 2009 Aug;6(8):793-811. doi: 10.1517/17425240903089310.
3
New treatments for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的新疗法。
Ann Ist Super Sanita. 2003;39(4):573-82.
4
[Novel therapeutics for COPD].[慢性阻塞性肺疾病的新型疗法]
Nihon Rinsho. 2011 Oct;69(10):1826-30.
5
Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.慢性阻塞性肺疾病患者使用压力定量吸入器：证据综述
Expert Rev Respir Med. 2014 Jun;8(3):349-56. doi: 10.1586/17476348.2014.905916. Epub 2014 May 7.
6
Emerging drugs for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的新兴药物。
Expert Opin Emerg Drugs. 2012 Mar;17(1):61-82. doi: 10.1517/14728214.2012.660917. Epub 2012 Feb 16.
7
Accuracy of inhaler use in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者吸入器使用的准确性。
Clin Nurs Res. 2014 Oct;23(5):560-74. doi: 10.1177/1054773813498269. Epub 2013 Aug 5.
8
[Efficient treatments for COLD in the twenty-first century?].[21世纪治疗感冒的有效方法？]
Presse Med. 2004 Jul 31;33(13):845-6. doi: 10.1016/s0755-4982(04)98769-6.
9
Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models.哮喘和慢性阻塞性肺疾病的新型药物靶点：从体外和体内模型中获得的经验教训。
Pulm Pharmacol Ther. 2014 Dec;29(2):181-98. doi: 10.1016/j.pupt.2014.05.008. Epub 2014 Jun 11.
10
Emerging pharmacotherapies for COPD.慢性阻塞性肺疾病（COPD）的新兴药物治疗方法。
Chest. 2008 Dec;134(6):1278-1286. doi: 10.1378/chest.08-1385.
引用本文的文献
1
Pulmonary Emphysema: Current Understanding of Disease Pathogenesis and Therapeutic Approaches.肺气肿：对疾病发病机制和治疗方法的当前认识
Biomedicines. 2025 Aug 30;13(9):2120. doi: 10.3390/biomedicines13092120.
2
Network Pharmacology and Experimental Verification Reveal the Regulatory Mechanism of Chuanbeimu in Treating Chronic Obstructive Pulmonary Disease.网络药理学与实验验证揭示川贝母治疗慢性阻塞性肺疾病的作用机制。
Int J Chron Obstruct Pulmon Dis. 2024 Mar 21;19:799-813. doi: 10.2147/COPD.S442191. eCollection 2024.
3
Bronchoalveolar Lavage Fluid from Chronic Obstructive Pulmonary Disease Patients Increases Neutrophil Chemotaxis Measured by a Microfluidic Platform.慢性阻塞性肺疾病患者的支气管肺泡灌洗液可增强通过微流控平台测量的中性粒细胞趋化性。
Micromachines (Basel). 2023 Sep 6;14(9):1740. doi: 10.3390/mi14091740.
4
cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features.慢性阻塞性肺疾病中的环磷酸腺苷磷酸二酯酶信号传导：细胞、分子及临床特征综述
Biochem Biophys Rep. 2023 Feb 16;34:101438. doi: 10.1016/j.bbrep.2023.101438. eCollection 2023 Jul.
5
The association between leukocyte telomere length and chronic obstructive pulmonary disease is partially mediated by inflammation: a meta-analysis and population-based mediation study.白细胞端粒长度与慢性阻塞性肺疾病的相关性部分受炎症影响：一项荟萃分析和基于人群的中介研究。
BMC Pulm Med. 2022 Aug 20;22(1):320. doi: 10.1186/s12890-022-02114-8.
6
The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness.获取伦理：一位艾滋病活动家赢得了公众获取实验性疗法的权利，现在这一权利必须扩展到用于精神疾病的迷幻药。
Front Psychiatry. 2021 Jul 5;12:680626. doi: 10.3389/fpsyt.2021.680626. eCollection 2021.
7
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles.使用类脂质-聚合物杂化纳米颗粒优化治疗性抗炎TNF-α siRNA向活化巨噬细胞的细胞内递送
Front Bioeng Biotechnol. 2021 Jan 14;8:601155. doi: 10.3389/fbioe.2020.601155. eCollection 2020.
8
Xiaoqinglong Decoction Attenuates Chronic Obstructive Pulmonary Disease in Rats via Inhibition of Autophagy.小青龙汤通过抑制自噬减轻大鼠慢性阻塞性肺疾病
Evid Based Complement Alternat Med. 2018 Jan 31;2018:6705871. doi: 10.1155/2018/6705871. eCollection 2018.
9
Time Course of the Phenotype of Blood and Bone Marrow Monocytes and Macrophages in the Lung after Cigarette Smoke Exposure In Vivo.体内香烟烟雾暴露后肺中血液及骨髓单核细胞和巨噬细胞表型的时间进程
Int J Mol Sci. 2017 Sep 9;18(9):1940. doi: 10.3390/ijms18091940.
10
The Isosteroid Alkaloid Imperialine from Bulbs of Fritillaria cirrhosa Mitigates Pulmonary Functional and Structural Impairment and Suppresses Inflammatory Response in a COPD-Like Rat Model.来自川贝母鳞茎的等甾体生物碱帝贝碱减轻慢性阻塞性肺疾病样大鼠模型的肺功能和结构损伤并抑制炎症反应
Mediators Inflamm. 2016;2016:4192483. doi: 10.1155/2016/4192483. Epub 2016 Jul 20.
本文引用的文献
1
New concepts in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的新概念
Annu Rev Med. 2003;54:113-29. doi: 10.1146/annurev.med.54.101601.152209. Epub 2001 Dec 3.
2
New treatments for COPD.慢性阻塞性肺疾病的新疗法。
Nat Rev Drug Discov. 2002 Jun;1(6):437-46. doi: 10.1038/nrd820.
3
Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.慢性阻塞性肺疾病（COPD）患者痰液样本中趋化因子GROα和单核细胞趋化蛋白-1（MCP-1）水平升高。
Thorax. 2002 Jul;57(7):590-5. doi: 10.1136/thorax.57.7.590.
4
Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者肺泡巨噬细胞释放基质金属蛋白酶-9及金属蛋白酶组织抑制因子-1的情况与活性
Am J Respir Cell Mol Biol. 2002 May;26(5):602-9. doi: 10.1165/ajrcmb.26.5.4685.
5
Thiol-dependent enzymes and their inhibitors: a review.硫醇依赖性酶及其抑制剂：综述
Curr Med Chem. 2002 May;9(9):979-1002. doi: 10.2174/0929867024606704.
6
A pilot study of all-trans-retinoic acid for the treatment of human emphysema.全反式维甲酸治疗人类肺气肿的初步研究。
Am J Respir Crit Care Med. 2002 Mar 1;165(5):718-23. doi: 10.1164/ajrccm.165.5.2106123.
7
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.噻托溴铵治疗1年期间慢性阻塞性肺疾病患者健康状况改善
Eur Respir J. 2002 Feb;19(2):209-16. doi: 10.1183/09031936.02.00238702.
8
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.噻托溴铵每日一次吸入治疗慢性阻塞性肺疾病的长期评估
Eur Respir J. 2002 Feb;19(2):217-24. doi: 10.1183/09031936.02.00269802.
9
The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo.新型磷酸二酯酶4抑制剂罗氟司特对运动诱发的哮喘有效，并能在体外抑制脂多糖刺激的肿瘤坏死因子-α。
J Clin Pharmacol. 2002 Mar;42(3):297-303. doi: 10.1177/00912700222011328.
10
Animal models of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的动物模型
Thorax. 2001 Dec;56(12):972-7. doi: 10.1136/thorax.56.12.972.
Zotero 插件